Key Record Dates
ClinicalTrials.gov Identifier: | NCT03069352 |
---|---|
Brief Title: | A Study of Venetoclax in Combination With Low Dose Cytarabine Versus Low Dose Cytarabine Alone in Treatment Naive Patients With Acute Myeloid Leukemia Who Are Ineligible for Intensive Chemotherapy |
First Submitted : | February 28, 2017 |
First Submitted that Met QC Criteria : | February 28, 2017 |
First Posted : | March 3, 2017 |
Results First Submitted : | February 14, 2020 |
Results First Submitted that Met QC Criteria : | February 14, 2020 |
Results First Posted : | February 28, 2020 |
Last Update Submitted that Met QC Criteria : | June 27, 2023 |
Last Update Posted : | July 3, 2023 |